Loading...
Please wait, while we are loading the content...
Solid organ transplant recipients during COVID‐19 pandemic
| Content Provider | Scilit |
|---|---|
| Author | Marcault, Clémence Fodil, Sofiane Dupont, Thibault Darmon, Michael Azoulay, Elie |
| Copyright Year | 2020 |
| Description | Journal: American Journal of Transplantation We read with interest the correspondence from Montagud-Marrahi et al. putting forward that solid organ transplant (SOT) recipients are not at higher risk of severe COVID-19 infection despite their immunosuppression and the mild or atypical nature of their symptoms in their Spanish cohort. In the recent literature, this population achieves a mortality rate between 20% and 52% when they become critically ill. Moreover, as innate immunity is altered by the infection, decreased doses of immunosuppressive drugs should be considered. |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300947/pdf |
| Ending Page | 2961 |
| Page Count | 2 |
| Starting Page | 2960 |
| e-ISSN | 16006143 |
| DOI | 10.1111/ajt.16126 |
| Journal | American Journal of Transplantation |
| Issue Number | 10 |
| Volume Number | 20 |
| Language | English |
| Publisher | Wiley-Blackwell |
| Publisher Date | 2020-10-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: American Journal of Transplantation Clinical Research/practice Heart Transplantation/cardiology Immune Deficiency Immunosuppressant Immunosuppression/immune Modulation Infection and Infectious Agents – Viral Infectious Disease |
| Content Type | Text |
